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Departments of Surgery and Anesthesiology, University of North Carolina at Chapel Hill, Chapel Hill, North CarolinaBackground. The purpose of this study was to (1)
determine the incidence of postoperative urinary reten-
tion (POUR) in patients undergoing lung resection at our
institution, (2) identify differences in potential risk fac-
tors between patients with and without POUR, and (3)
describe patient outcomes across POUR status.
Methods. The medical records of 225 patients between
2016 and 2017 were reviewed, and 191 met criteria for
inclusion. The institution’s catheterization removal pro-
tocol was followed in all patients. Recatheterization was
defined as requiring in-and-out catheterization or Foley
catheter placement. Fisher exact and Wilcoxon tests were
used for analysis.
Results. POUR developed in 35 patients (18%). Pa-
tients with POUR were older (P [ .01), had increased
baseline creatinine (P [ .04), and a higher prevalence of
benign prostatic hyperplasia (P [ .007). POUR patients
were also less likely to get a Foley catheterAccepted for publication Dec 23, 2019.
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such as surgical approach and extent of resection, were
not significantly different between patients with and
without POUR. Postoperative factors (epidural use or
days with chest tube) were similar. Although patients
with POUR were more likely to be discharged with a
Foley catheter (13% vs 0%, P [ .002), no difference in
length of stay, incidences of urinary tract infections, or
30-day readmission were observed.
Conclusions. POUR develops in approximately 1 in 5
patients undergoing lung resection. Patients with POUR
were more likely to not have a Foley catheter placed
intraoperatively. However, patients who had POUR did
not have worsened patient outcomes (urinary tract in-
fections, length of stay, or 30-day readmission).ostoperative urinary retention (POUR), which is thePinability to void in the presence of a full bladder, is a
well-described complication after procedures, with an
overall incidence of 2% to 40%.1 Although well-described
after abdominal procedures, the incidence of POUR after
thoracic surgery operations has only been described in a
select group of patients (nearing 12% in patients under-
going minor thoracic procedures).2 POUR may lead to
urinary tract infections and prolonged hospital length of
stay and is associated with patient-specific (age, sex,
history of benign prostatic hyperplasia), anesthesia-
specific (fluid administration, use of anticholinergic
medications, and postoperative use of epidural and
opioid analgesia), and operation-specific (duration of
operation) risk factors or a combination of these.1,3
Because POUR may be a multifactorial problem, we
sought to (1) determine the incidence of POUR in patientsundergoing lung resection at our institution, (2) identify
differences in potential risk factors between patients with
and without POUR, and (3) describe patient outcomes
across POUR status.
Patients and Methods
Study Population and Data Collection
The medical records of 225 patients who underwent lung
resections between June 1, 2016, and November 31, 2017,
were reviewed for inclusion. Patients were excluded if
they underwent concomitant procedures, died during the
hospital stay, or were anuric or had a urostomy at base-
line (n ¼ 21). In addition, for 13 patients who underwent
multiple operations during the study period, only the first
procedure was included. The institution’s catheterization
removal protocol was followed in all patients (Figure 1).
POUR was defined as requiring recatheterization (in-and-
out catheterization or Foley catheter placement) within 5
days postoperatively and captured by reviewing the
electronic medical record, where voids and bladder scan
values are recorded by time.
We defined POUR as in-and-out catheterization or
Foley catheter placement within 5 days postoperatively.
Figure 1. Bladder catheter removal protocol.Patients who had an in-and-out catheterization had 3
attempts before placement of an indwelling catheter.
Furthermore, if a patient required an indwelling catheter
placement, the catheter was removed after 48 hours, and
the bladder scan protocol was reinitiated. Not all patients
with POUR were discharged with a Foley. There is no
standardized protocol that dictates who undergoes Foley
catheterization in the operating room. Not all patients
underwent Foley catheters placement intraoperatively
before their operation. It is standard at our institution for
patients who are undergoing robotic thoracic surgery or
an anticipated lobectomy to have a Foley catheter placed
intraoperatively. In these cases, the catheter is always
placed after induction with general anesthesia. However,
for operations that are anticipated to be short (<2 hours),
a Foley catheter is not always placed and is not placed
during the hospitalization unless POUR develops.
Collected variables included known perioperative risk
factors for POUR, such as male sex and history of benign
prostatic hyperplasia, and baseline demographics. Intra-
operative variables included approach, extent of resec-
tion, and intraoperative resuscitation. Postoperative
variables included days with chest tube, intercostal nerve
blockade, and opiate use. The complete list of variables is
included in Table 1. Opioid use was collected for the first
5 days postoperatively and converted to morphine milli-
gram equivalents (MME). Outcomes included length of
stay, development of urinary tract infection, presence of
Foley at discharge, and readmission rates.
All data extraction was conducted within the standard of
the University of North Carolina’s Institutional Review
Board Committee (Study number 15-1841). The require-
ment for consent from individual study participants was
waived given the retrospective nature of thismedical record
review.
Statistical Analyses
Patient demographics, surgical characteristics, and out-
comes were compared between patients with and withoutPOUR using Fisher exact and Wilcoxon tests, where
appropriate. A P value of less than .05 was considered
statistically significant. Analyses were performed using
SAS 9.4 software (SAS Institute, Inc, Cary, NC).Results
Of the 191 patients included in the analysis, and POUR
developed in 35 patients (18%), and they required reca-
theterization during their hospitalization: 15 were in-and-
out catheterizations (43%), and 20 were Foley catheter
placements (57%). Median time to POUR, among these
patients, was postoperative day 1 (interquartile range
[IQR], 1-3 days; range, 0-8 days) (Figure 2).
Patients with POUR were older (median 67 vs 63 years,
P ¼ .01), had an increased frequency of benign prostatic
hyperplasia (28% vs 3%, P ¼ .007), had increased baseline
creatinine (median 0.9 mg/dL vs 0.8 mg/dL, P ¼ .04), and
used tamsulosin more frequently (14% vs 3%, P ¼ .02)
compared with patients who did not have POUR. Of note,
9 of 10 patients who used tamsulosin preoperatively were
restarted on tamsulosin by postoperative day 1. The
incidence of developing POUR appeared to be higher in
male patients, but the difference was not statistically
significant (57% vs 38%, P ¼ .06).
Intraoperative factors, such as surgical approach, extent
of resection, use of anticholinergic medication, intercostal
nerve blockade, and the amount of resuscitation, were not
significantly different between patients with and without
POUR (Table 1). The only difference between groups was
that patients with POUR less commonly had an intra-
operative Foley placed (66% vs 83%, P ¼ .03).
There were no differences in postoperative factors,
such as epidural use or days with chest tube, between
POUR and non-POUR patients. Postoperative day (POD)
0 (ie, the day of the procedure) and overall 5-day post-
operative opioid use was similar between patients with
and without POUR (POD 0: 48 [IQR, 34-66] MME vs 50
[IQR, 35-69] MME, P ¼ .55; and POD 5: 85 [IQR, 66-115]
MME vs 93 [IQR, 62-153] MME, P ¼ .39).
Although patients with POUR were more frequently
discharged with a Foley catheter (14% vs 0%, P ¼ .0002),
no differences were seen in length of stay or incidences of
urinary tract infection, 30-day emergency department
visits, and 30-day readmission (Table 2). For the 5 patients
discharged with a Foley catheter, duration of Foley use
and number of nonthoracic surgery follow-up appoint-
ments are described in Table 3. In general, patients
followed-up with a local urologist or primary care
physician for trial of void or with a urologist in our sys-
tem. With our limited data given the follow-up appoint-
ments scheduled outside our system, patients typically
required between 0 and 2 follow-up visits in the first 30
days, and the Foley was removed within 2 weeks.Comment
Overall, we found that the incidence of POUR in the lung
resection population is relatively high, with POUR
developing in almost 1 in every 5 patients. This is




P Valuen ¼ 35 (18%) n ¼ 156 (82%)
Male 20 (57) 60 (38) .06
Age, y 67 (60-73) 63 (54-69) .01
White 29 (83) 108 (70) .15
Comorbidities
Benign prostatic hyperplasiaa 5 (28) 2 (3) .007
Diabetes 10 (29) 26 (17) .15
Malignancy 26 (76) 125 (81) .63
Preoperative
Creatinine, mg/dL 0.9 (0.8-1.1) 0.8 (0.7-1.0) .04
FEV1, % 72 (64-88) 82 (64-96) .16
Tamsulosin 5 (14) 5 (3) .02
Surgical approach
VATS 23 (66) 98 (63) .99
Robotic 3 (9) 15 (10) .
Open 3 (9) 14 (9) .
Convert to open 6 (17) 29 (19) .
Laterality
Right 22 (63) 90 (58) .71
Left 13 (37) 61 (39) .
Bilateral 0 (0) 5 (3) .
Resection extent
Single lobe 20 (57) 84 (56) .96
Double lobe 1 (3) 3 (2) .
Wedge 14 (40) 62 (41) .
Other 0 (0) 2 (1) .
Operative time, h 2.4 (1.4-3.9) 2.4 (1.6-3.4) .92
Total colloid, mL 250 (175-500) 250 (250-500) .56
Total crystalloid, mL 1000 (700-1450) 1000 (647-1400) .71
Estimated blood loss, mL 50 (30-200) 100 (30-150) .71
Glycopyrrolate dose, mg 0.6 (0.5-0.8) 0.6 (0.5-0.8) .87
Epidural 4 (11) 36 (24) .17
Epidural duration, d 4 (3-6) 3 (2-4) .65
Chest tube duration, db 3 (1-5) 3 (2-4) .59
Intraoperative Foley 23 (66) 130 (83) .03
Intercostal block 31 (89) 121 (78) .17
Total inpatient opioidsc, MME 85 (66-115) 93 (62-153) .39
aAmong male patients only; bChest tubes in 2 patients were removed after their discharge date; cInpatient opioid use during postoperative days
0 to 5 (or discharge) during their hospitalization; patients with POUR before postoperative day 5 had opioid use after their diagnosis included from
the total.
Continuous data are presented as median (interquartile range) and categorical data as n (%).
FEV1, forced expiratory volume in 1 second; MME, morphine milligram equivalent; POUR, postoperative urinary retention; VATS, video-assisted thor-
acoscopic surgery.consistent with other studies which have demonstrated
that procedures typically requiring at least a 1- to 2-day
inpatient hospitalization have higher rates of POUR.4
This patient population had a slightly higher incidence of
POUR compared with a study by Kim and colleagues2
looking at thoracic surgery patients. The Kim study found
an 11% incidence of POUR, but patients who received an
intraoperative indwelling catheter were excluded, making
direct comparison a challenge. Our study also confirmedknown risk factors for POUR, namely age and benign
prostatic hyperplasia.1,4-8 It also suggests that male sex
may increase the risk of POUR, although additional
research is needed to confirm this result.
Interestingly, very few intraoperative and postoperative
risk factors that were analyzed were associated with a
higher incidence of POUR, making it difficult to develop
targets for improvement. Of particular note, patients with
POUR did not more commonly have an epidural placed
Figure 2. Cumulative incidence of postoperative urinary retention
(POUR) by postoperative day.for analgesic administration. Other studies have demon-
strated an association between epidural use and POUR,
but this was not observed in our small study.4,9,10 Unlike
historical lung resection cohorts,11 we had a relatively
lower epidural placement rate (w20%). Patients who are
more likely to require a thoracotomy (due to size or
location of the lung mass or who have chest wall
involvement) based on preoperative imaging are consid-
ered for preoperative epidural catheter placement. All
other patients undergo intercostal nerve blockade intra-
operatively with liposomal bupivacaine.
Interestingly, patients with POUR less frequently had a
Foley placed intraoperatively. Bladder distention during
an operation (>790 mL) may lead to POUR.12,13 There-
fore, one target for improvement is to place indwelling
catheters for longer cases. Nurse-driven bladder removal
protocols with strict bladder scanning policies have also
been shown to decrease the incidence of POUR.14Table 2. Patient Outcomes
Outcome
POUR No POUR
P Valuen ¼ 35 (18%) n ¼ 156 (82%)
Urinary tract infection 0 (0) 4 (3) 0.99
Length of stay, d 6 (4-8) 5 (4-7) 0.19
Discharge with Foley 5 (14) 0 (0) 0.0002
30-day ED visit 5 (14) 23 (15) 0.99
30-day readmission 6 (17) 15 (10) 0.24
Categorical data are presented as n (%) and continuous data as median
(interquartile range).
ED, emergency department; POUR, postoperative urinary retention.Assessing the potential impact of opioid use on POUR
was a challenge because there was no comparable opioid
duration in patients without POUR. We therefore
compared overall 5-day opioid use, which includes opi-
oids received after POUR diagnosis, and POD 0 opioid
use, neither of which was significantly different.
Almost every patient who was taking tamsulosin (9 of
10 patients), an a-blocker known to improve urinary
retention symptoms in patients with benign prostatic
hyperplasia,15 was restarted on this medication by POD 1.
Although the results regarding the use of prophylactic
tamsulosin in patients at high risk of developing POUR
are mixed,15,16 the standard of care at our institution is to
restart tamsulosin postoperatively for patients who take it
on an outpatient basis. Despite largely adhering to this
standard, patients with POUR had higher preoperative
tamsulosin use.
Finally, an important take away from this study is that
while POUR is a frequent occurrence in patients under-
going lung resection, occurring in almost 1 in 5 patients,
POUR was not associated with many negative patient
outcomes in our study. Patients with POUR were more
commonly discharged home with a Foley catheter but did
not have longer hospital stays or higher 30-day read-
mission rates. This is in contrast to previous studies.17
Furthermore, the incidence of urinary tract infections, one
of the common complications associated with urinary
catheter use, in our patient population was very low (2%).
This fact, combined with the observation that patients
with POUR often had no intraoperative Foley catheter
placed, suggests that intraoperative Foley catheter
placement may be beneficial in appropriately selected
patients.
Study Limitations
This study has several limitations. First, the limitations of
our study include all the caveats of a small, non-
randomized study with limited follow-up. Owing to the
limited study size, we could not perform a multivariate
analysis to elucidate the association of other variables
with the studied outcomes. Given the relatively rare
occurrence of POUR, this study may be underpowered to
detect significant differences between risk factors. Future
studies that include a larger sample size and power
analysis need to be conducted to determine risk factors
for POUR.
In addition, we could not capture readmissions outside
of our medical system because they are not linked to our
electronic medical record, making the duration of
outpatient Foley use and number of outpatient visits after
discharge difficult to capture. We likely underestimated
the total 30-day readmission rate, but there is likely no
difference in this underestimation between POUR and
non-POUR patients.
Our patient population also had a very low incidence of
urinary tract infection and 30-day readmission, which
limited our ability to detect differences in such outcomes.
Finally, important patient outcomes, such as patient
satisfaction and quality of life, were not assessed. For
example, although developing POUR may not increase a
Table 3. Use When Discharged With a Foley Catheter
Patient Duration Foley Use Past Discharge, d Follow-up Visits, No. Notes
1 Unknown 0 Follow-up with local PCP for Foley removal
2 Unknown 0 Readmitted within 2 weeks
3 8 2
4 <14 1 Follow-up with local urologist
5 6 2
No., number; PCP, primary care physician.patient’s length of stay, it may cause an increase in
dissatisfaction. Future studies should include patient
satisfaction measures when assessing the effect of POUR
on patient outcomes.
Nonetheless, this study presents a descriptive study of
the incidence of POUR in a broad population of lung
resection patients. Its findings that intraoperative Foley
use may be protective and epidural use may not be a risk
factor will be useful for future studies.
Conclusion
POUR develops in approximately 1 in 5 patients under-
going lung resection. These patients with POUR were
more likely to not have a Foley catheter placed intra-
operatively. However, patients who had POUR did not
have worsened patient outcomes (urinary tract infection,
length of stay, 30-day readmission).References
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